Avanos Medical Inc (AVNS)vsEdwards Lifesciences Corp (EW)
AVNS
Avanos Medical Inc
$25.05
+0.20%
HEALTHCARE · Cap: $1.17B
EW
Edwards Lifesciences Corp
$85.96
-1.70%
HEALTHCARE · Cap: $49.01B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 781% more annual revenue ($6.30B vs $715.90M). EW leads profitability with a 17.4% profit margin vs -10.4%. EW earns a higher WallStSmart Score of 61/100 (C+).
AVNS
Hold37
out of 100
Grade: F
EW
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AVNS.
Margin of Safety
+68.7%
Fair Value
$253.29
Current Price
$85.96
$167.33 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
16.7% revenue growth
Areas to Watch
Smaller company, higher risk/reward
ROE of -8.9% — below average capital efficiency
Earnings declined 21.7%
Negative free cash flow — burning cash
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : AVNS
The strongest argument for AVNS centers on Price/Book, Debt/Equity.
Bull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bear Case : AVNS
The primary concerns for AVNS are Market Cap, Return on Equity, EPS Growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Key Dynamics to Monitor
AVNS profiles as a turnaround stock while EW is a growth play — different risk/reward profiles.
AVNS carries more volatility with a beta of 1.59 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
AVNS generates stronger free cash flow (-17M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 37/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Avanos Medical Inc
HEALTHCARE · MEDICAL DEVICES · USA
Avanos Medical, Inc. is a medical technology company focused on providing medical device solutions to improve the quality of life for patients in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is headquartered in Alpharetta, Georgia.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?